Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
2009
Therapy for von Willebrand disease (VWD) aims to restore the hemostatic function conferred by von Willebrand factor (VWF), which facilitates platelet adhesion and aggregation, and serves to increase potentially low coagulation factor VIII (FVIII) in plasma. In patients unresponsive to desmopressin (
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
53
References
36
Citations
NaN
KQI